Wu et al.
(19 000), 331sh (13 000), 486 (1600). CV: E1/2 ) -1.00 V (RuIII/II).
Anal. Calcd (Found) for C18H20N3O4Ru‚0.2H2O: C, 48.36 (47.89);
by UV-vis titration (Figure S4 in the Supporting Information).
Inside a glove box, solutions of 5 (0.053 mM), [N(tol)3]PF6 (2.7
mM), and TEMPO-H (2.7 mM) in MeCN were prepared at room
temperature. An aliquot of 5 (2.5 mL) in a UV-vis cuvette was
titrated with 0.1 equiv (5 µL) increments of [N(tol)3]PF6 until 1
equiv, as 6 was generated. UV-vis of 6: 455 (4700), 508 (3400).
The solution was further titrated with increments of 0.1 equiv (5
µL) of TEMPO-H until 1 equiv, as 4 was produced. The yield for
4 was 100 ( 10% on the basis of starting 5. CV: E1/2 ) -0.07 V
(RuIII/II) for 6, generated from 5 (2.5 mM, 2.0 mL) + 1 equiv of
[N(tol)3]PF6 (62 mM, 80 µL) in MeCN.
1
H, 4.60 (4.51); N, 9.40 (9.35); H NMR spectra of 3 in CD3CN
typically show ∼0.2 equiv of H2O per ruthenium although an NMR
spectrum of the batch sent for elemental analysis was not obtained.
RuII(hfac)2(py-imH) (4). A solution of cis-RuII(hfac)2(MeCN)2
(1000 mg, 1.67 mmol) and py-imH (420 mg, 2.89 mmol) in C6H6
(50 mL) was refluxed for 16 h under air. The solvent was removed
on a rotary evaporator, and the residue was loaded onto a silica
gel column and eluted with 9:1 CH2Cl2/CH3OH. The first brown
fraction was unreacted cis-RuII(hfac)2(MeCN)2 (207 mg, 21%), and
4 was isolated as the second red-brown fraction, which was rotary
evaporated to dryness, reprecipitated with CH2Cl2/hexanes, filtered,
and dried in vacuo at 78 °C. Yield: 298 mg (27%). 1H NMR (CD3-
CN): 6.20 (s, 2H, hfac-H); 7.42 (t), 7.97 (t), 8.09 (d), 8.48 (d) (1H
each, py-H, 3JHH ) 6-8 Hz); 7.22, 7.49 (d, 1H each, im-CH, 3JHH
) 2 Hz); 11.82 (s, 1H, im-NH). 19F NMR (CD3CN): -75.06,
-75.04, -74.99, -74.94 (s, hfac-CF3). 13C{1H} NMR (CD3OD):
92.81, 93.00 (hfac-CH); 117.84, 117.86, 119.02, 119.09 (q, hfac-
CF3,1JCF ) 282 Hz); 120.83, 124.81, 137.99, 153.41 (py-CH);
121.53, 132.38 (im-CH); 149.67, 153.26 (py-N-C-C-N-im);
168.94, 169.10, 172.35, 172.53 (q, hfac-C(O), 2JCF ) 33 Hz). ESI/
MS+: 661 (M+). UV-vis: 291 (26 000), 481sh (9600), 519
(10 000). CV: E1/2 ) 0.29 V (RuIII/II). Anal. Calcd (Found) for
C18H9F12N3O4Ru: C, 32.74 (32.80); H, 1.37 (1.38); N, 6.36 (6.54).
[DBU-H][RuII(hfac)2(py-im)] (5). DBU (25 µL, 0.165 mmol)
was added to a red-brown solution of 4 (109 mg, 0.165 mmol) in
MeCN (10 mL) under air to immediately generate a dark-purple
solution, which was rotary evaporated to dryness. The residue was
reprecipitated with CH2Cl2/hexanes to yield a black-purple solid,
which was filtered and dried in vacuo at 78 °C. Yield: 102 mg
(76%). 1H NMR (CD3CN): 1.70 (m, 6H), 1.98 (quintet, 2H), 2.60
(m, 2H), 3.30 (t, 2H), 3.46 (t, 2H), 3.52 (m, 2H) (DBU-H+); 6.11,
6.12 (s, 1H each, hfac-H); 7.06 (t), 7.71 (t), 7.87 (d), 8.21 (d) (1H
each, py-H, 3JHH ) 6-8 Hz); 6.99, 7.19 (d, 1H each, im-CH, 3JHH
) 2 Hz). 19F NMR (CD3CN): -75.06, -74.91, -74.88, -74.74
(s, hfac-CF3). 13C{1H} NMR (CD3OD): 20.43, 24.94, 27.49, 29.96,
33.78, 39.42, 49 (overlapped with CD3OD), 55.36 (DBU-CH2);
93.38, 93.47 (hfac-CH); 118.23, 119.74, 119.58 (q, hfac-CF3,1JCF
) 282 Hz), the fourth quartet is obscured by overlapping with py-
CH; 118.56, 121.18, 137.01, 152.09 (py-CH); 129.80, 132.11 (im-
CH); 155.76, 167.45 (py-N-C-C-N-im); 158.29 (DBU-NdC-
RuII(acac)2(py-imnH) (7). Complex 7 was synthesized analo-
gous to 1 using cis-RuII(acac)2(MeCN)2 (200 mg, 0.52 mmol) and
py-imnH (93 mg, 0.63 mmol) and was isolated as a black-green
1
powder. Yield: 121 mg (52%). H NMR (CD3CN): 1.55 (3H),
1.60 (3H), 2.00 (6H) (s, acac-CH3); 3.6-4.0 (m, 4H, imn-CH),
5.27, 5.31 (s, 1H each, acac-CH); 6.12 (s, 1H, imn-NH); 7.12 (t),
3
7.49 (t), 7.61 (d), 8.74 (d) (1H each, py-H, JHH ) 6-8 Hz). An
adequate 13C{1H} NMR spectrum has not been obtained because
of low solubility of 7. EI/MS: 447 [M]+, 348 [M - acac]+, 300
[M - py-imnH]+, 282, 276, 260, 248. UV-vis: 274 (24 000), 428
(6900), 610 (7700). CV: E1/2 ) -0.68 V (RuIII/II). Anal. Calcd
(found) for C18H23N3O4Ru: C, 48.42 (48.13); H, 5.19 (5.26); N,
9.41 (9.38).
RuII(hfac)2(py-imnH) (8). Complex 8 was synthesized analogous
to 4 except using cis-RuII(hfac)2(MeCN)2 (200 mg, 0.33 mmol) and
py-imnH (99 mg, 0.67 mmol) and was isolated as a brown-purple
powder. Yield: 62 mg (28%). 1H NMR (CD3CN): 3.72 (1H), 3.85
(1H), 4.00 (2H) (m, imn-CH); 6.17, 6.20 (s, 1H each, hfac-H);
6.90 (s, 1H, imn-NH); 7.50 (t), 7.95 (t), 7.97 (d), 8.54 (d) (1H each,
3
py-H, JHH ) 6-8 Hz). 19F NMR (CD3CN): -75.14, -75.11,
-75.01, -74.83 (s, hfac-CF3). 13C{1H} NMR (CD3OD): 46.12,
55.58 (imn-CH); 92.86 (both hfac-CH); 117.89, 117.96, 119.04,
119.12 (q, hfac-CF3,1JCF ) 282 Hz); 125.02, 127.16, 137.45, 153.84
(py-CH); 152.92, 169.34 (py-N-C-C-N-imn); 168.22, 169.59,
172.25, 172.50 (q, hfac-C(O), 2JCF ) 33 Hz). ESI/MS+: 663 (M+).
UV-vis: 225 (6200), 269 (5300), 289 (5300), 484sh (4200), 524
(5300). CV: E1/2 ) 0.14 V (RuIII/II). Anal. Calcd (Found) for
C18H11F12N3O4Ru: C, 32.64 (32.82); H, 1.67 (1.67); N, 6.34 (6.30).
1H NMR Titration of 2 and 3. Stock solutions were prepared
for DBU (111 mM, 16.9 mg in 1 mL) and HOTf (111 mM, 16.7
mg in 1 mL) in CD3CN. A solution of 3 in an NMR tube (11 mM,
2.5 mg in 0.5 mL CD3CN) was titrated to 2 by adding 1 equiv of
HOTf in 0.1 equiv (5 µL) increments. 1H NMR spectra were
recorded initially and after each addition of HOTf. Each peak in
the spectra was a weighted average of the corresponding peaks for
2 and 3, indicating fast proton exchange on the NMR time scale.
The reverse titration, adding 1 equiv of DBU in 0.1 equiv (5 µL)
2
N); 165.70, 166.68, 170.13, 170.83 (q, hfac-C(O), JCF ) 33 Hz).
ESI/MS+: 661 [M + H]+, 153 (DBU-H+); ESI/MS-: 660 (M-).
UV-vis: 292 (20 000), 472 (8300), 564 (11 000). CV: E1/2
)
-0.07 V (RuIII/II). Anal. Calcd (Found) for C27H25F12N5O4Ru: C,
39.91 (39.92); H, 3.10 (3.11); N, 8.62 (8.74).
In Situ Generation of RuIII(hfac)2(py-im) (6) and Reaction
of 6 + TEMPO-H. In a N2 glove box, solutions of 5 (2.5 mM, 4.0
mg in 2.0 mL), [N(tol)3]PF6 (61.5 mM, 26.6 mg in 1 mL), and
TEMPO-H (123 mM, 38.7 mg in 2.0 mL) in CD3CN were prepared
at room temperature. A trace amount of (Me3Si)2O was added to
the solution of 5 as internal standard. Each of three J-Young NMR
tubes were filled with 0.5 mL of the solution of 5. To tubes 2 and
3 was added 1 equiv of [N(tol)3]PF6 (20 µL), with immediate color
changes from purple-red to pale-brown 6. After mixing tube 3 well,
1 equiv of TEMPO-H (10 µL) was added, giving an immediate
1
increments, was also monitored by H NMR.
UV-Vis Titration of 2 and pKa Determination. Stock solutions
were prepared for 2 (0.11 mM), DBU (6.5 mM), and HOTf
(6.5 mM) in MeCN. An aliquot of 2 (3.0 mL, 0.11 mM) was
transferred to a UV-vis cuvette and was titrated with increments
of 0.1 equiv (5 µL) of DBU. UV-vis spectra were recorded for
the initial 2 and after each addition of DBU. A total of 1.3 equiv
of DBU was added, but the spectrum stopped changing after 1.0
equiv, showing a stoichiometric conversion to the deprotonated 3.
The titration was reversible, and protonated 2 was regenerated
stoichiometrically by 1 equiv of HOTf, by adding 0.1 equiv (5 µL)
increments.
1
color change to red-brown 4. The H NMR spectrum of tube 2
after ∼20 min showed resonances of DBU-H+, N(tol)3 [δ 2.27
(s, 9H, CH3); 6.87, 7.07 (d, 6H each, Ar-H, 3JHH ) 7 Hz)], and a
trace of 4; paramagnetic 6 was not observed. The 1H NMR spectrum
of tube 3 showed 100 ( 10% yield for 4, on the basis of the
integration of starting 5. The generation of 6 was also monitored
A stock solution of 2,4-lutidine (647 mM) in MeCN was
prepared, and was serial diluted twice to make two other solutions
(64.7 and 6.47 mM). An aliquot of 2 (3.0 mL, 0.11 mM) was
11200 Inorganic Chemistry, Vol. 46, No. 26, 2007